Friday, September 24, 2021 3:13:52 PM
Who is dreaming up the cynical abstractions — holders of public shares who are entitled to information, or self-dealing c-suiters who hold as much information as close to their own chests as possible?
No one is questioning the idea of contracting in general. The question is whether it’s beneficial to shareholders to have the CEO of their company setting herself (and, possibly, unknown partners) up as the sole contractor upon which success of their investment depends. She pays herself, in the form of Toucan/Advent, with money from NWBio’s coffers. Is NWBio getting a good deal? If so, let’s see the books.
That other tycoons might set up similar self-dealing arrangements is no argument for their ethical standing or benefit to shareholders. They certainly benefit the negotiators. In this case “the negotiators” are principally one person.
No one is questioning the idea of contracting in general. The question is whether it’s beneficial to shareholders to have the CEO of their company setting herself (and, possibly, unknown partners) up as the sole contractor upon which success of their investment depends. She pays herself, in the form of Toucan/Advent, with money from NWBio’s coffers. Is NWBio getting a good deal? If so, let’s see the books.
That other tycoons might set up similar self-dealing arrangements is no argument for their ethical standing or benefit to shareholders. They certainly benefit the negotiators. In this case “the negotiators” are principally one person.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
